Polygala tenuifolia extract
Polygala Tenuifolia Extract (Yuan Zhi) · also known as Polygala root, Polygala saponins, Polygala, TEN-60
In animal and cell studies, Polygala tenuifolia extract can affect BDNF/TrkB signaling, brain monoamine metabolism and NMDA-related neurotoxicity. Its brain targets, effects on long-term potentiation and rapid mood effects have not been reliably verified in humans.
Clinical uses and human evidence
Memory
Mechanisms of action
Neurotrophic factor synthesis and TrkB/A receptor activation
In chronically stressed rats, Polygala extract can affect hippocampal BDNF and TrkB mRNA expression, but the evidence is mainly limited to animals. There is no reliable trial evidence in humans for rapid TrkB activation or synaptic long-term potentiation, and an antidepressant effect cannot be inferred from these findings.
Monoamine neurotransmitter balance (dopamine, norepinephrine, 5-HT)
Animal experiments suggest Polygala can alter brain monoamine-related metabolism. In vitro, some Polygala oligosaccharide esters inhibit norepinephrine transport only at micromolar concentrations, and the claim that they inhibit all three transporters at once lacks human evidence.
References (2)
- Li 2024 · Rat pharmacokinetic and metabolomics study: Polygala extract was linked to changes in brain monoamine-related metabolism
- Cheng 2006 · In-vitro study: some Polygala oligosaccharide esters inhibited norepinephrine transport, with a half-maximal inhibitory concentration in the micromolar range
GABA and glutamate balance (inhibitory and excitatory tone)
In cultured neurons, Polygala can reduce NMDA-induced damage, but this does not mean it directly blocks the NMDA ion channel. There is currently no reliable evidence for direct receptor antagonism or for a neuroprotective effect in humans.